Anti-FceR1 alpha [Mar-1]

Absolute Antibody

Anti-FceR1 alpha [Mar-1]

9

This antibody specifically targets the non-signalling alpha chain of the FceR1 complex.

This antibody has been used in flow cytometric analysis of FceR1 alpha cell surface expression by basophils (Min et al, 2004; Chen et al, 2009), and immunohistochemical analysis of epidermal sheets (Holzmann et al, 2004). It has also been used in immunoprecipitation analysis of cell lysates from lung cDCs and MC/9 mast cells (Grayson et al, 2007). In vitro incubation of basophils with this antibody blocks subsequent MAR-1 staining, but does not activate basophil IL-4 production (Sokol et al, 2008). Intravenous treatment of mice with this antibody results in basophil depletion in peripheral blood, spleen, bone marrow and liver, but not skin or intraperitoneal mast cell depletion (Sokol et al, 2008). Following treatment with this antibody, basophil-depleted mice display impaired Th2 differentiation upon papain immunisation (Sokol et al, 2008). However, MAR-1 treated mice respond normally to high-dose intravenous Ig in both the K/BxN serum transfer arthritis and collagen-induced arthritis models, despite basophil depletion (Campbell et al, 2014).

Flow Cytometry, ImmunoPrecipitation, ImmunoHistoChemistry, Other Application

Research Use Only

Monoclonal

MAR-1

Fcer1a

Fc receptor, IgE, high affinity I, alpha polypeptide

FcE; Fce1; Fce1a; fc-epsilon RI-alpha; fcepsilonri; FcERI; Fcr-; Fcr-5; high affinity immunoglobulin epsilon receptor subunit alpha; igE Fc receptor subunit alpha

Mouse

IgG2a

High affinity immunoglobulin epsilon receptor subunit alpha

This chimeric mouse antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques.

Mouse

-20°C,2°C to 8°C

12352203